Continuous treatment with anti-BTK and anti-BCL-2 therapies is typically required in the management of CLL, and the success of these therapies is heavily dependent on the emergence of drug resistance over time
The chapter serves as a catalyst for further exploration into the balance between conventional and alternative cancer therapies
Am Fam Phys 70:19351944 Park HR, Lee JM, Moon HE, Lee DS, Kim BN, Kim J, Kim DG, Paek SH (2016) A Short review on the current understanding of autism spectrum disorders
[DOI] [PMC free article] [PubMed] [Google Scholar] Migaud, M
Xu for help with generating the orthotopic lung cancer and liver metastasis models, S
Briefly, Nrf2 is a transcription factor that is bound to the protein Kelch-like ECH-associated protein 1 (Keap1) in the cytosol ( Figure 3 )